Jeffrey Bluestone - Jul 14, 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Edward S. Son by Power of Attorney for Jeffrey A. Bluestone
Stock symbol
GILD
Transactions as of
Jul 14, 2025
Transactions value $
-$211,450
Form type
4
Date filed
7/15/2025, 03:59 PM
Previous filing
May 8, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bluestone Jeffrey Director 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Jeffrey A. Bluestone 2025-07-15 0001771814

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $337K +5K +56.05% $67.45 13.9K Jul 14, 2025 Direct F1
transaction GILD Common Stock Sale -$549K -5K -35.92% $109.74 8.92K Jul 14, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -5K -34.09% $0.00 9.67K Jul 14, 2025 Common Stock 5K $67.45 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.
F2 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.